Abbott Laboratories logo

Abbott Laboratories (ABL)

Market Closed
10 Nov, 20:00
XBER XBER
108. 76
-0.08
-0.07%
- Market Cap
36.49 P/E Ratio
2.2% Div Yield
0 Volume
4.44 Eps
108.84
Previous Close
Day Range
107.94 109.32
Year Range
103.7 134.34
Want to track ABL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 71 days

Summary

ABL closed today lower at €108.76, a decrease of 0.07% from yesterday's close, completing a monthly decrease of -4.43% or €5.04. Over the past 12 months, ABL stock lost -0.48%.
ABL pays dividends to its shareholders, with the most recent payment made on Aug 15, 2025. The next announced payment will be in In 6 days on Nov 17, 2025 for a total of €0.59.
The last earnings report, released on Oct 15, 2025, missed the consensus estimates by -1.3%. On average, the company has fell short of earnings expectations by -0.43%, based on the last three reports. The next scheduled earnings report is due on Jan 21, 2026.
Abbott Laboratories has completed 8 stock splits, with the recent split occurring on Jan 02, 2013.
The company's stock is traded on 16 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ABL Chart

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 5 days ago
Goldman Sachs Still Says Sell-Off Coming – 5 Safe Conviction List Picks

Goldman Sachs Still Says Sell-Off Coming – 5 Safe Conviction List Picks

Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest United States corporations by total revenue.

247wallst | 2 weeks ago
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 2 weeks ago

Abbott Laboratories (ABL) FAQ

What is the stock price today?

The current price is €108.76.

On which exchange is it traded?

Abbott Laboratories is listed on NYSE.

What is its stock symbol?

The ticker symbol is ABL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.2%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 1.5.

When is the next earnings date?

The next earnings report will release on Jan 21, 2026.

Has Abbott Laboratories ever had a stock split?

Abbott Laboratories had 8 splits and the recent split was on Jan 02, 2013.

Abbott Laboratories Profile

Medical - Devices Industry
Healthcare Sector
Robert B. Ford CEO
XBER Exchange
US0028241000 ISIN
US Country
114,000 Employees
15 Oct 2025 Last Dividend
2 Jan 2013 Last Split
13 Jan 1978 IPO Date

Overview

Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.

Products and Services

Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:

  • Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
  • Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
  • Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
  • Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.

Contact Information

Address: 100 Abbott Park Road
Phone: 224 667 6100